Ambit develops data-driven software platforms that identify and activate patients with rare diseases for biopharma companies. Their solutions enhance patient engagement and streamline the process of locating specialty patients, addressing the challenges of patient identification in commercial and pre-commercial settings.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biopharmaceutical companies face significant challenges in identifying and engaging patients with rare diseases due to limited awareness, diagnostic complexities, and geographically dispersed populations. Traditional methods of patient identification are often inefficient, leading to delays in treatment and hindering clinical trial recruitment.
Solution
Ambit provides data-driven software solutions that enable biopharma companies to identify and activate patients with rare and specialty diseases. Their platform leverages AI/ML modeling and rules-based triggers to generate high-quality leads for healthcare professionals (HCPs), facilitating timely interventions. Ambit's end-to-end patient-finding capabilities streamline the process of locating patients for both commercial and pre-commercial purposes, while omni-channel engagement extends coverage to target HCPs beyond the reach of field teams. By providing advanced analytics and personalized solutions, Ambit helps biopharma companies overcome the hurdles of patient identification and improve patient outcomes.
Target Audience
The primary target audience includes biopharmaceutical companies specializing in rare and specialty diseases, as well as commercial and medical affairs teams focused on patient identification and engagement.
Features
- AI/ML modeling for identifying potential patients with rare diseases
- Rules-based triggers for timely HCP lead generation
- Omni-channel engagement to reach a broader network of healthcare professionals
- End-to-end patient finding for commercial and pre-commercial applications
- Advanced analytics for personalized patient solutions
- Data-driven decision-making to improve patient outcomes